Valuation dashboard for McKesson Corporation (MCK) with P/E 26.61, P/B -27.84, EV/EBITDA 16.7 and dividend yield 0.34%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S.
What would it be worth at its usual multiples?
Versus its usual multiples: fairly priced · Current P/E 26.6× · Multiples range: $1,146.89 · $1,146.89.
At its sector median (30.7×) $1,147 (+15 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
Analysis Summary
McKesson Corporation reported revenue of $403.43B in the most recent fiscal year, growing at a 5-year CAGR of 11.1%.
Trailing-twelve-month margins: gross margin 3.6%, operating margin 1.6%, net margin 1.1%.
At $994.58 (closing price, October 30, 2026), MCK trades at a P/E of 26.61 and an ROE of -194.39%. Market capitalisation stands at $116.0B, placing it among large-cap names.
Balance sheet quality for MCK: debt-to-equity ratio of -2.76, current ratio of 0.89 over the last 12 months. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 26.61 |
| Price / Book | -27.84 |
| EV / EBITDA | 16.7 |
| Dividend Yield | 0.34% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| MCK | McKesson Corporation | $116.0B | 26.61 | -194.4% | |
| COR | Cencora, Inc. | $63.1B | 24.58 | 20.94 | 106.4% |
| CAH | Cardinal Health, Inc. | $58.0B | 34.64 | -59.7% | |
| 0JZU.L | McKesson Corporation | $117.5B | 26.67 | -194.4% | |
| 0HF3.L | Cencora, Inc. | $63.6B | 24.48 | 20.95 | 106.4% |
| 0HTG.L | Cardinal Health, Inc. | $58.9B | 34.33 | -59.7% | |
| HSIC | Henry Schein, Inc. | $9.5B | 24.75 | 3.05 | 12.4% |
| 0L3C.L | Henry Schein, Inc. | $9.4B | 24.55 | 3.05 | 12.4% |
Price
| Price | $994.58 (closing price, October 30, 2026) |
| Market Cap | $116.0B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | -194.39% |
| Return on Invested Capital | 27.91% |
| Return on Assets | 5.20% |
| Gross Margin | 3.64% |
| Operating Margin | 1.62% |
| Net Margin | 1.12% |
Related companies: COR · CAH · 0JZU.L · 0HF3.L · 0HTG.L · HSIC · 0L3C.L
Explore sector: Healthcare · Medical - Distribution
More sections of MCK: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks